From the Laboratory of Veterinary Clinical Oncology, Department of Veterinary Medicine (A.M., M.M., T.M.), Gifu University, Gifu, Japan.
From the Animal Medical Center (S.G., R.I.), Gifu University, Gifu, Japan.
J Am Anim Hosp Assoc. 2022 Jul 1;58(4):189-193. doi: 10.5326/JAAHA-MS-7199.
The prognosis for bile duct carcinoma in dogs is generally believed to be poor. However, only a few studies have evaluated the postoperative outcomes in such cases. The objective of this case series was to describe the postoperative outcomes of localized intrahepatic bile duct carcinoma in dogs. The electronic medical records of 16 dogs with bile duct carcinoma were reviewed, and 6 dogs were included in the study. All cases were diagnosed as bile duct carcinoma using postoperative pathology, and five of them had already been diagnosed using preoperative core biopsy. The tumors in all of the dogs were confirmed as completely resected on histopathological examination. Two dogs received toceranib following the surgery. The median follow-up time was 693 days (range, 420-1386 days), with a median survival time of 894 days (range, 420-1386 days). Local recurrence or distant metastases were detected in two of the six dogs (33%) on 354 and 398 days following surgery, respectively. The median progression-free survival was 492 days (range, 354-1386 days). In conclusion, dogs with localized intrahepatic bile duct carcinoma had a good prognosis following complete surgical resection.
犬胆管癌的预后一般被认为较差。然而,仅有少数研究评估了此类病例的术后结果。本病例系列旨在描述犬局限性肝内胆管癌的术后结果。回顾了 16 例胆管癌犬的电子病历,其中 6 例被纳入研究。所有病例均通过术后病理诊断为胆管癌,其中 5 例术前通过核心活检诊断。所有犬的肿瘤在组织病理学检查中均证实完全切除。2 只犬在手术后接受了toceranib 治疗。中位随访时间为 693 天(范围,420-1386 天),中位生存时间为 894 天(范围,420-1386 天)。术后 354 天和 398 天,分别有 2 只犬(33%)检测到局部复发或远处转移。无进展生存期的中位数为 492 天(范围,354-1386 天)。总之,完全手术切除后,犬局限性肝内胆管癌有良好的预后。